Oncogenic nature of a novel mutant AATF and its interactome existing within human cancer cells

被引:11
|
作者
Sharma, Shaveta [1 ]
Kaul, Deepak [1 ]
Arora, Mansi [1 ]
Malik, Deepti [1 ]
机构
[1] Postgrad Inst Med Educ & Res, Mol Biol Unit, Dept Expt Med & Biotechnol, Chandigarh 160012, India
关键词
Cancer cells; DNMT3B; Mutant-AATF; Oncogenomics; AUTOPHAGY; APOPTOSIS; P53; SURVIVAL; CHE-1;
D O I
10.1002/cbin.10379
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Since apoptosis presents a natural defense in cancer development, the anti-apoptotic factor AATF/Che-1 has emerged as a crucial Epigenomic-Switch'. We have tried to understand the double-edged nature of AATF, showing for the first time the conspicuous existence of an aberrant AATF/Che-1 transcriptome encoding for 23kDa mutant AATF protein, which evolves its unique interactome within human cancer cells derived from different tissue origins. This mutant AATF along with its interactome consisting of SP1, DNMT3B and Par-4 ensures cancer cell DNA methylation required for down-regulation of tumor suppressor genes. Hence, the proposed mutant AATF interactome-based pathway can have the inherent ability to ensure human cells become and remain cancerous.
引用
收藏
页码:326 / 333
页数:8
相关论文
共 50 条
  • [1] Elucidation of the Pax-5/miRNA interactome and its oncogenic effects in cancer cells
    Robichaud, Gilles Andre
    Harquail, Jason
    Beauregard, Annie-Pier
    Hannay, Brandon
    FASEB JOURNAL, 2019, 33
  • [2] CMIP is oncogenic in human gastric cancer cells
    Zhang, Jianlin
    Huang, Jin
    Wang, Xingyu
    Chen, Weidong
    Tang, Qinqing
    Fang, Maoyong
    Qian, Yeben
    MOLECULAR MEDICINE REPORTS, 2017, 16 (05) : 7277 - 7286
  • [3] Regulation of Autophagy in Cells Infected With Oncogenic Human Viruses and Its Impact on Cancer Development
    Vescovo, Tiziana
    Pagni, Benedetta
    Piacentini, Mauro
    Fimia, Gian Maria
    Antonioli, Manuela
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [4] Protein interactome between PTEN and cancer-associated mutant demonstrated the regulatory pathway of migration through its novel interactors
    Goh, Mei Xian
    Gunaratne, Jayantha
    Swa, Lee Foon
    Sanford, Emma M.
    Lee, Fen Yee
    Hogue, Kelly A.
    Blackstock, Walter
    Okumura, Koichi
    CANCER RESEARCH, 2011, 71
  • [5] Exploiting signaling rewiring in cancer cells with co-existing oncogenic drivers
    Chiarle, Roberto
    Ambrogio, Chiara
    MOLECULAR ONCOLOGY, 2023, 17 (11) : 2215 - 2217
  • [6] HOTAIR LncRNA: A novel oncogenic propellant in human cancer
    Rajagopal, Taruna
    Talluri, Srikanth
    Akshaya, R. L.
    Dunna, Nageswara Rao
    CLINICA CHIMICA ACTA, 2020, 503 : 1 - 18
  • [7] Sensitivity of human cells bearing oncogenic mutant kit isoforms to the novel tyrosine kinase inhibitor INNO-406
    Pan, Jingxuan
    Quintas-Cardama, Alfonso
    Manshouri, Taghi
    Cortes, Jorge
    Kantarjian, Hagop
    Verstovsek, Srdan
    CANCER SCIENCE, 2007, 98 (08): : 1223 - 1225
  • [8] Characterization of the Translationally Controlled Tumor Protein (TCTP) Interactome Reveals Novel Binding Partners in Human Cancer Cells
    Li, Siting
    Chen, Minghai
    Xiong, Qian
    Zhang, Jia
    Cui, Zongqiang
    Ge, Feng
    JOURNAL OF PROTEOME RESEARCH, 2016, 15 (10) : 3741 - 3751
  • [9] CD73 is a novel repressor of mutant β-catenin oncogenic activity in endometrial cancer
    Hirsch, Rebecca M.
    Zhang, Xingyuan
    Chiou, Lilly F.
    Premsankar, Sunthoshini
    Lee, Hannah N.
    Kurnit, Katherine C.
    Broaddus, Russell R.
    Vaziri, Cyrus
    Bowser, Jessica L.
    CLINICAL CANCER RESEARCH, 2024, 30 (05)
  • [10] Oncogenic potential of a mutant human thyrotropin receptor expressed in FRTL-5 cells
    Fournes, B
    Monier, R
    Michiels, F
    Milgrom, E
    Misrahi, M
    Feunteun, J
    ONCOGENE, 1998, 16 (08) : 985 - 990